Article
Semi-synthetic DNA shuffling of aveC leads to improved industrial scale production of doramectin by Streptomyces avermitilis.
Metabolic engineering - 1 Jan 2005
Stutzman-Engwall Kim, Conlon Steve, Fedechko Ronald, McArthur Hamish, Pekrun Katja, Chen Yan, Jenne Stephane, La Charlene, Trinh Na, Kim Seran, Zhang Ying-Xin, Fox Richard, Gustafsson Claes, Krebber Anke
Abstract excerpt
The avermectin analog doramectin (CHC-B1), sold commercially as Dectomax, is biosynthesized by Streptomyces avermitilis. aveC, a gene encoding an unknown mechanistic function, plays an essential role in the production of doramectin (avermectin CHC-B1), modulating the production ratio of CHC-B1 to other avermectins, most notably the undesirable analog CHC-B2. To improve the production ratio for doramectin, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
